Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-07 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-07 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |